Extending a lifeline to people with HIV and opioid use disorder during the war in Ukraine.
Extending a lifeline to people with HIV and opioid use disorder during the war in Ukraine.
复制标题
DOI:
10.1016/s2468-2667(22)00083-4
复制
发表时间:
2022-05
影响因子:
50
通讯作者:
Madden, Lynn M.
中科院分区:
文献类型:
--
作者:
Altice, Frederick L.;Bromberg, Daniel J.;Dvoriak, Sergii;Meteliuk, Anna;Pykalo, Iryna;Islam, Zahedul;Azbel, Lyu;Madden, Lynn M.
Oleksander navigates a bomb-shelled northern Ukrainian city between air raid sirens. He is on his way to the clinic to collect methadone for his opioid use disorder—a trip he has made regularly since 2016. However, this time the situation is quite different. 3 days earlier he sent his wife and children to Lviv for safety and has been living with 20 other men in the basement of his building, which doubles as a bomb shelter. Water has been disrupted and food is increasingly scarce. Yesterday, his doctor texted him a 30-min window to pick up his methadone, when emergency sirens are less common. The doctor dispenses a 10-day supply and Oleksander is relieved. He was not sure how much he would receive with the crisis worsening. Before the COVID-19 pandemic, he went to collect his methadone daily but, since the pandemic began, take-home doses have been permitted, making it easier for him to work and take care of his family. In non-occupied Ukraine, both methadone and buprenorphine are available as medications for opioid use disorder. Although grateful to receive today’s supply of methadone, Oleksander asks for an increased supply, just in case the Russian army takes over. Even though Ukraine’s Ministry of Health has just released new guidance allowing for a 30-day supply, his doctor is reluctant because he needs to keep enough for his other patients or for new patients that might be fleeing the east. His doctor is also concerned about disruptions in the supply chain and delivery of more medications for opioid use disorder.Treatment programmes and their staff throughout the country are struggling to navigate the needs of their patients. Some doctors are reducing dosages to prolong supplies while others are dispensing what they have because they are uncertain when new medications will arrive. The consequences of a disrupted supply chain to patients are substantial. Tapering the dose every few days will result in a prolonged period of physically and emotionally uncomfortable side-effects from withdrawal symptoms. However, running out of medication abruptly will result in serious side-effects from withdrawal symptoms. In either case, withdrawal symptoms from opioids will not only accentuate the stresses and anxieties of war, but many patients could then relapse to injectable opioids, elevating their risk for overdose, skin and soft tissue infections, and transmission of blood-borne viruses such as HIV or hepatitis C virus. Approximately half of all people on methadone are also being treated for HIV, 1 and the discontinuation of methadone could result in high rates of discontinuation from HIV medications, which could accelerate progression of HIV or, in the case of ongoing HIV risk-taking, transmit HIV to others.